Market OverviewThe global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period.
Background. Transrectal ultrasound—guided (TRUS) prostate biopsy is a commonly performed procedure, and fluoroquinolones are the most frequently given prophylactic antimicrobials. In the context of ...
The global transrectal ultrasound (TRUS) market is expected to grow at a steady CAGR of around 6% during the forecast period. The market growth is driven by the rising prevalence of prostate cancer, ...
Local anesthetic transperineal (LATP) biopsy for prostate cancer detection is gaining in popularity due to concerns about infectious complications with transrectal ultrasound (TRUS) biopsy. LATP ...
Non-infiltrative anesthetics are safe and effective in treating pain from transrectal prostate biopsy, according to research from the Department of Urology and Renal Transplantation at the University ...
Povidone-iodine cleansing plus formalin disinfection of the needle is a "simple, low-cost, and effective" nonantibiotic strategy to decrease infectious complications following transrectal ultrasound ...
Under adequate local anesthesia, the size of the transrectal ultrasound probe made no difference to pain perception during transrectal ultrasound guided prostate biopsy, according to a PubMed report.
Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or abiraterone acetate plus ...
The report suggests that high-resolution micro-ultrasound could help identify clinically significant lesions that would be missed with conventional MRI. High-resolution micro-ultrasound (micro-US) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results